Consequently, Liang et al.'s findings showed that macrophages decrease the sensitivity of osteosarcoma cells to chemotherapy agents by secreting IL-1β during neoadjuvant chemotherapy, implying a potential decrease in chemotherapy efficacy in the osteosarcoma microenvironment (Liang et al., 2020). This evidence concerns the gene IL1B and osteosarcoma.